A biotechnology company develops new and innovative disease treatments. They own no manufacturing facilities of their own, and are considering how best to produce their products. Which is NOT one of the key questions should they ask to decide the best possible approach? Group of answer choices How tradable is manufacturing capacity? How well can we integrate with a manufacturing partner? Where should we produce our product? Are our internal resources relevant to manufacturing